nodes	percent_of_prediction	percent_of_DWPC	metapath
Trandolapril—ACE—forelimb zeugopod—peripheral nervous system neoplasm	0.0206	0.379	CbGeAlD
Trandolapril—ACE—forelimb—peripheral nervous system neoplasm	0.0104	0.19	CbGeAlD
Trandolapril—ACE—arm—peripheral nervous system neoplasm	0.0089	0.164	CbGeAlD
Trandolapril—ACE—nerve—peripheral nervous system neoplasm	0.00567	0.104	CbGeAlD
Trandolapril—ACE—ganglion—peripheral nervous system neoplasm	0.0056	0.103	CbGeAlD
Trandolapril—Perindopril—BCHE—peripheral nervous system neoplasm	0.00546	0.314	CrCbGaD
Trandolapril—Ramipril—BCHE—peripheral nervous system neoplasm	0.00466	0.268	CrCbGaD
Trandolapril—SLC15A2—parotid gland—peripheral nervous system neoplasm	0.00226	0.0415	CbGeAlD
Trandolapril—Perindopril—ABCB1—peripheral nervous system neoplasm	0.00214	0.123	CrCbGaD
Trandolapril—Cilazapril—ABCB1—peripheral nervous system neoplasm	0.00189	0.108	CrCbGaD
Trandolapril—Lisinopril—ABCB1—peripheral nervous system neoplasm	0.00189	0.108	CrCbGaD
Trandolapril—Enalapril—ABCB1—peripheral nervous system neoplasm	0.00138	0.0795	CrCbGaD
Trandolapril—SLC15A2—cerebellum—peripheral nervous system neoplasm	0.00105	0.0192	CbGeAlD
Trandolapril—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000528	0.000569	CcSEcCtD
Trandolapril—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000526	0.000567	CcSEcCtD
Trandolapril—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000526	0.000566	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000525	0.000565	CcSEcCtD
Trandolapril—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000521	0.000562	CcSEcCtD
Trandolapril—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00052	0.000561	CcSEcCtD
Trandolapril—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.00052	0.00056	CcSEcCtD
Trandolapril—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000518	0.000558	CcSEcCtD
Trandolapril—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000513	0.000553	CcSEcCtD
Trandolapril—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000512	0.000551	CcSEcCtD
Trandolapril—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000511	0.000551	CcSEcCtD
Trandolapril—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.00051	0.00055	CcSEcCtD
Trandolapril—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000507	0.000546	CcSEcCtD
Trandolapril—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000506	0.000546	CcSEcCtD
Trandolapril—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000505	0.000544	CcSEcCtD
Trandolapril—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000503	0.000542	CcSEcCtD
Trandolapril—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000501	0.00054	CcSEcCtD
Trandolapril—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000501	0.00054	CcSEcCtD
Trandolapril—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.0005	0.000539	CcSEcCtD
Trandolapril—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000498	0.000536	CcSEcCtD
Trandolapril—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000496	0.000535	CcSEcCtD
Trandolapril—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000495	0.000533	CcSEcCtD
Trandolapril—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000495	0.000533	CcSEcCtD
Trandolapril—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000495	0.000533	CcSEcCtD
Trandolapril—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000493	0.000531	CcSEcCtD
Trandolapril—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000489	0.000527	CcSEcCtD
Trandolapril—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000489	0.000527	CcSEcCtD
Trandolapril—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000489	0.000527	CcSEcCtD
Trandolapril—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000489	0.000527	CcSEcCtD
Trandolapril—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000488	0.000526	CcSEcCtD
Trandolapril—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000488	0.000526	CcSEcCtD
Trandolapril—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000485	0.000523	CcSEcCtD
Trandolapril—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000485	0.000523	CcSEcCtD
Trandolapril—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000484	0.000521	CcSEcCtD
Trandolapril—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000482	0.00052	CcSEcCtD
Trandolapril—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000481	0.000518	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000481	0.000518	CcSEcCtD
Trandolapril—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00048	0.000518	CcSEcCtD
Trandolapril—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00048	0.000517	CcSEcCtD
Trandolapril—Constipation—Etoposide—peripheral nervous system neoplasm	0.000476	0.000513	CcSEcCtD
Trandolapril—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000476	0.000512	CcSEcCtD
Trandolapril—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000475	0.000512	CcSEcCtD
Trandolapril—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000472	0.000509	CcSEcCtD
Trandolapril—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000472	0.000508	CcSEcCtD
Trandolapril—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00047	0.000507	CcSEcCtD
Trandolapril—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000469	0.000505	CcSEcCtD
Trandolapril—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000469	0.000505	CcSEcCtD
Trandolapril—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000464	0.000499	CcSEcCtD
Trandolapril—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000463	0.000499	CcSEcCtD
Trandolapril—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000462	0.000497	CcSEcCtD
Trandolapril—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000459	0.000494	CcSEcCtD
Trandolapril—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000458	0.000494	CcSEcCtD
Trandolapril—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000457	0.000492	CcSEcCtD
Trandolapril—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000457	0.000492	CcSEcCtD
Trandolapril—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000455	0.000491	CcSEcCtD
Trandolapril—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000455	0.00049	CcSEcCtD
Trandolapril—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000454	0.000489	CcSEcCtD
Trandolapril—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000453	0.000488	CcSEcCtD
Trandolapril—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000453	0.000488	CcSEcCtD
Trandolapril—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000453	0.000488	CcSEcCtD
Trandolapril—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00045	0.000485	CcSEcCtD
Trandolapril—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000449	0.000484	CcSEcCtD
Trandolapril—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000449	0.000484	CcSEcCtD
Trandolapril—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000448	0.000482	CcSEcCtD
Trandolapril—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000447	0.000482	CcSEcCtD
Trandolapril—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000447	0.000481	CcSEcCtD
Trandolapril—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.00048	CcSEcCtD
Trandolapril—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000442	0.000477	CcSEcCtD
Trandolapril—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.00044	0.000475	CcSEcCtD
Trandolapril—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00044	0.000474	CcSEcCtD
Trandolapril—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00044	0.000474	CcSEcCtD
Trandolapril—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.00044	0.000474	CcSEcCtD
Trandolapril—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000439	0.000473	CcSEcCtD
Trandolapril—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000437	0.000471	CcSEcCtD
Trandolapril—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000436	0.00047	CcSEcCtD
Trandolapril—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000436	0.00047	CcSEcCtD
Trandolapril—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000434	0.000468	CcSEcCtD
Trandolapril—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000434	0.000467	CcSEcCtD
Trandolapril—Rash—Vincristine—peripheral nervous system neoplasm	0.000433	0.000467	CcSEcCtD
Trandolapril—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000433	0.000466	CcSEcCtD
Trandolapril—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000433	0.000466	CcSEcCtD
Trandolapril—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000432	0.000465	CcSEcCtD
Trandolapril—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000431	0.000464	CcSEcCtD
Trandolapril—Headache—Vincristine—peripheral nervous system neoplasm	0.000431	0.000464	CcSEcCtD
Trandolapril—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000428	0.000461	CcSEcCtD
Trandolapril—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000427	0.00046	CcSEcCtD
Trandolapril—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000424	0.000456	CcSEcCtD
Trandolapril—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000423	0.000456	CcSEcCtD
Trandolapril—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000423	0.000455	CcSEcCtD
Trandolapril—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000416	0.000448	CcSEcCtD
Trandolapril—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000415	0.000448	CcSEcCtD
Trandolapril—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000414	0.000446	CcSEcCtD
Trandolapril—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000411	0.000442	CcSEcCtD
Trandolapril—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00041	0.000442	CcSEcCtD
Trandolapril—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.00041	0.000441	CcSEcCtD
Trandolapril—Nausea—Vincristine—peripheral nervous system neoplasm	0.000408	0.00044	CcSEcCtD
Trandolapril—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000408	0.000439	CcSEcCtD
Trandolapril—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000408	0.000439	CcSEcCtD
Trandolapril—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000408	0.000439	CcSEcCtD
Trandolapril—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000406	0.000438	CcSEcCtD
Trandolapril—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000403	0.000435	CcSEcCtD
Trandolapril—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000401	0.000432	CcSEcCtD
Trandolapril—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.0004	0.000431	CcSEcCtD
Trandolapril—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000399	0.00043	CcSEcCtD
Trandolapril—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000399	0.00043	CcSEcCtD
Trandolapril—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000399	0.000429	CcSEcCtD
Trandolapril—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000398	0.000429	CcSEcCtD
Trandolapril—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000397	0.000428	CcSEcCtD
Trandolapril—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000396	0.000427	CcSEcCtD
Trandolapril—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000394	0.000424	CcSEcCtD
Trandolapril—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000392	0.000423	CcSEcCtD
Trandolapril—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000392	0.000422	CcSEcCtD
Trandolapril—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000388	0.000418	CcSEcCtD
Trandolapril—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000386	0.000416	CcSEcCtD
Trandolapril—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000385	0.000415	CcSEcCtD
Trandolapril—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000384	0.000414	CcSEcCtD
Trandolapril—Rash—Cisplatin—peripheral nervous system neoplasm	0.000383	0.000413	CcSEcCtD
Trandolapril—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000383	0.000412	CcSEcCtD
Trandolapril—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000382	0.000412	CcSEcCtD
Trandolapril—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000381	0.00041	CcSEcCtD
Trandolapril—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.00038	0.000409	CcSEcCtD
Trandolapril—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000379	0.000408	CcSEcCtD
Trandolapril—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000377	0.000406	CcSEcCtD
Trandolapril—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000377	0.000406	CcSEcCtD
Trandolapril—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000377	0.000406	CcSEcCtD
Trandolapril—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000374	0.000403	CcSEcCtD
Trandolapril—Back pain—Epirubicin—peripheral nervous system neoplasm	0.00037	0.000399	CcSEcCtD
Trandolapril—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000369	0.000397	CcSEcCtD
Trandolapril—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000368	0.000397	CcSEcCtD
Trandolapril—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000368	0.000396	CcSEcCtD
Trandolapril—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000367	0.000396	CcSEcCtD
Trandolapril—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000366	0.000395	CcSEcCtD
Trandolapril—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.000391	CcSEcCtD
Trandolapril—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000361	0.000389	CcSEcCtD
Trandolapril—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000359	0.000387	CcSEcCtD
Trandolapril—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000356	0.000384	CcSEcCtD
Trandolapril—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000355	0.000382	CcSEcCtD
Trandolapril—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000354	0.000381	CcSEcCtD
Trandolapril—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000354	0.000381	CcSEcCtD
Trandolapril—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000353	0.000381	CcSEcCtD
Trandolapril—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000351	0.000379	CcSEcCtD
Trandolapril—Rash—Etoposide—peripheral nervous system neoplasm	0.000351	0.000378	CcSEcCtD
Trandolapril—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000351	0.000378	CcSEcCtD
Trandolapril—Headache—Etoposide—peripheral nervous system neoplasm	0.000349	0.000376	CcSEcCtD
Trandolapril—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000349	0.000376	CcSEcCtD
Trandolapril—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000347	0.000373	CcSEcCtD
Trandolapril—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000345	0.000372	CcSEcCtD
Trandolapril—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000344	0.00037	CcSEcCtD
Trandolapril—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000343	0.000369	CcSEcCtD
Trandolapril—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000342	0.000369	CcSEcCtD
Trandolapril—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000342	0.000369	CcSEcCtD
Trandolapril—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.00034	0.000367	CcSEcCtD
Trandolapril—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000338	0.000364	CcSEcCtD
Trandolapril—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000336	0.000362	CcSEcCtD
Trandolapril—Cough—Epirubicin—peripheral nervous system neoplasm	0.000334	0.00036	CcSEcCtD
Trandolapril—Nausea—Etoposide—peripheral nervous system neoplasm	0.000331	0.000356	CcSEcCtD
Trandolapril—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000328	0.000354	CcSEcCtD
Trandolapril—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000327	0.000352	CcSEcCtD
Trandolapril—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000326	0.000351	CcSEcCtD
Trandolapril—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000326	0.000351	CcSEcCtD
Trandolapril—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000326	0.000351	CcSEcCtD
Trandolapril—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000325	0.00035	CcSEcCtD
Trandolapril—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000324	0.00035	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000323	0.000348	CcSEcCtD
Trandolapril—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000322	0.000347	CcSEcCtD
Trandolapril—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000319	0.000344	CcSEcCtD
Trandolapril—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000318	0.000343	CcSEcCtD
Trandolapril—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.000343	CcSEcCtD
Trandolapril—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000317	0.000342	CcSEcCtD
Trandolapril—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000317	0.000341	CcSEcCtD
Trandolapril—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000313	0.000337	CcSEcCtD
Trandolapril—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000312	0.000336	CcSEcCtD
Trandolapril—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000311	0.000335	CcSEcCtD
Trandolapril—Infection—Epirubicin—peripheral nervous system neoplasm	0.00031	0.000334	CcSEcCtD
Trandolapril—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000309	0.000333	CcSEcCtD
Trandolapril—Shock—Epirubicin—peripheral nervous system neoplasm	0.000307	0.000331	CcSEcCtD
Trandolapril—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000306	0.00033	CcSEcCtD
Trandolapril—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000306	0.000329	CcSEcCtD
Trandolapril—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000305	0.000328	CcSEcCtD
Trandolapril—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000303	0.000327	CcSEcCtD
Trandolapril—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000302	0.000325	CcSEcCtD
Trandolapril—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000325	CcSEcCtD
Trandolapril—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000325	CcSEcCtD
Trandolapril—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000325	CcSEcCtD
Trandolapril—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.0003	0.000323	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.000322	CcSEcCtD
Trandolapril—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000321	CcSEcCtD
Trandolapril—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000321	CcSEcCtD
Trandolapril—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.000317	CcSEcCtD
Trandolapril—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000292	0.000314	CcSEcCtD
Trandolapril—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000289	0.000311	CcSEcCtD
Trandolapril—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.000309	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000284	0.000306	CcSEcCtD
Trandolapril—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.000306	CcSEcCtD
Trandolapril—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.000305	CcSEcCtD
Trandolapril—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.000305	CcSEcCtD
Trandolapril—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000282	0.000304	CcSEcCtD
Trandolapril—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000304	CcSEcCtD
Trandolapril—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000302	CcSEcCtD
Trandolapril—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.00028	0.000302	CcSEcCtD
Trandolapril—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.000301	CcSEcCtD
Trandolapril—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000278	0.0003	CcSEcCtD
Trandolapril—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000277	0.000299	CcSEcCtD
Trandolapril—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.000297	CcSEcCtD
Trandolapril—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000275	0.000296	CcSEcCtD
Trandolapril—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000271	0.000292	CcSEcCtD
Trandolapril—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.000291	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000269	0.00029	CcSEcCtD
Trandolapril—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000269	0.00029	CcSEcCtD
Trandolapril—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000267	0.000288	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.000283	CcSEcCtD
Trandolapril—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000281	CcSEcCtD
Trandolapril—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.000279	CcSEcCtD
Trandolapril—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000277	CcSEcCtD
Trandolapril—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000277	CcSEcCtD
Trandolapril—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000277	CcSEcCtD
Trandolapril—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000255	0.000275	CcSEcCtD
Trandolapril—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.000274	CcSEcCtD
Trandolapril—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.00027	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.000269	CcSEcCtD
Trandolapril—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.000268	CcSEcCtD
Trandolapril—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000267	CcSEcCtD
Trandolapril—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000247	0.000266	CcSEcCtD
Trandolapril—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000266	CcSEcCtD
Trandolapril—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000266	CcSEcCtD
Trandolapril—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000256	CcSEcCtD
Trandolapril—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000254	CcSEcCtD
Trandolapril—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00023	0.000248	CcSEcCtD
Trandolapril—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000247	CcSEcCtD
Trandolapril—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000246	CcSEcCtD
Trandolapril—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000246	CcSEcCtD
Trandolapril—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000224	0.000241	CcSEcCtD
Trandolapril—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000221	0.000238	CcSEcCtD
Trandolapril—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000214	0.00023	CcSEcCtD
Trandolapril—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000229	CcSEcCtD
Trandolapril—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000223	CcSEcCtD
Trandolapril—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000206	0.000222	CcSEcCtD
Trandolapril—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.00022	CcSEcCtD
Trandolapril—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000214	CcSEcCtD
Trandolapril—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000213	CcSEcCtD
Trandolapril—Rash—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000212	CcSEcCtD
Trandolapril—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000212	CcSEcCtD
Trandolapril—Headache—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000211	CcSEcCtD
Trandolapril—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000206	CcSEcCtD
Trandolapril—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000185	0.0002	CcSEcCtD
Trandolapril—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000198	CcSEcCtD
Trandolapril—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000196	CcSEcCtD
Trandolapril—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000196	CcSEcCtD
Trandolapril—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000195	CcSEcCtD
Trandolapril—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000185	CcSEcCtD
